J7505 HCPCS Level II code: Muromonab-cd3, parenteral, 5 mg

CMS terminated J7505: its last date of service was Dec 31, 2025. It stays here for looking up older claims; newer services need a current code.

Official description

J7505

Muromonab-cd3, parenteral, 5 mg

Short description: Monoclonal antibodies

HCPCS · United States

Medicare details

The indicators CMS publishes with J7505 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Drugs
Type of service
Medical care; Immunosuppressive drugs
BETOS category
Other drugs
Added
Jan 1, 1988
Terminated after
Dec 31, 2025

Where J7505 sits

  1. 1J codesDrugs administered other than orally
  2. 2Terminated J7505Muromonab-cd3, parenteral, 5 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

Is HCPCS code J7505 still valid?

No. CMS terminated J7505; its last date of service was Dec 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.

Does Medicare cover J7505?

CMS lists J7505’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.